How This Works This blend combines three complementary peptides with distinct mechanisms: AOD-9604 is a modified C-terminal fragment of human growth hormone (amino acids 177191) that retains the lipolytic and anti-lipogenic properties of GH without stimulating IGF-1 or affecting glucose metabolism [1] [7]
Akita, K., Kawata, S
2,21 Nitric oxide (NO) affects vascular function and health by promoting blood vessel relaxation, regulating endothelial permeability, inhibiting blood clotting, and controlling vascular smooth muscle cell proliferation
Vehicle or MEDI4166 was dosed subcutaneously once weekly
A new study from researchers at the University of Hong Kong, published in Diabetes, Obesity and Metabolism , brings much-needed clarity to one of the most oft-cited concerns: Do GLP-1 receptor agonists cause muscle loss along with fat loss
In the recent TRANSCEND-T2D-1 trial (March 2026), Retatrutide reduced A1C by up to 2.0% in participants with type 2 diabetes